RVVTF Archives - Spark Newswire

3 minute read

Psyched: Canada’s Case For Psilocybin Access And Microdose Trial, US Reform Update, Battle With DEA & More

April 5, 9:57 AM

Canadian Patients Demand Access To Psilocybin: Federal Lawsuit, Official Petition & Failing Mechanism A patient-led lawsuit against the Canadian government is claiming access to therapeutic psilocybin is a constitutional right under the Canadian Charter of Rights and Freedoms.

IGXT

1 minute read

MDMA Transdermal Patch Moves Toward First-In-Human Trials: Latest Development Update

By Lara Goldstein

April 3, 3:46 PM

Specialty drug delivery technology biopharma company Revive Therapeutics Ltd. (OTCQB: RVVTF) is undertaking research and development activities for its proprietary transdermal microneedle patch to deliver MDMA toward IND-enabling studies, supported by an exclusive supply deal with PharmaAla Biotech Holdings Inc.

PHRRF

2 minute read

Meth Use Disorder Tackled With Psilocybin: Clinical Trial Begins Patient Enrollment

By Lara Goldstein

March 28, 2:31 PM

Life sciences company Revive Therapeutics Ltd.

RVVTF

3 minute read

PharmaTher Holdings Nabs New Orphan Drug Status, Discusses Further Fast-Track, Partners For MDMA Patch

By Lara Goldstein

February 3, 2:23 PM

Ketamine products manufacturer PharmaTher Holdings Ltd. (OTCQB: PHRRF) had lots happening this past week. Here are the company's top three news items.

PHRRF

4 minute read

Psyched: Psychedelics In Davos, Prince Harry In The 90s, Cathie Wood’s Latest Moves And More

By Lara Goldstein

January 17, 7:38 PM

Psychedelics Take Center Stage In Davos Psychedelics will lead the conversation inside the Davos House of Health for a second year in a row this January.

ATAI

1 minute read

Psychedelics Company Revive Raises $3.2M To Target Infectious Diseases, Disorders

By Lara Goldstein

January 12, 2:11 PM

Life sciences company Revive Therapeutics Ltd. (OTCQB: RVVTF) raised funds to treat infectious diseases and rare disorders, including meth addiction.<

RVVTF

4 minute read

Psyched: First Ayahuasca Pill Created, Psychedelics Legalization Predicted, UK’s Research Support And More

By Lara Goldstein

December 19, 9:23 PM

Ayahuasca Pill Is Officially Here, Filament CEO Discusses Future Plans The first medical-grade drug candidate of the psychedelic ayahuasca is being developed.

AWKNF

2 minute read

Psyence, Revive Therapeutics Ink Private Placements: Capital To Support Drug Trials

By Lara Goldstein

December 16, 5:46 PM

Life sciences biotech Psyence Group Inc. (OTCQB: PSYGF) has closed the second tranche of its previously announced private placement of up to $2.2 million (CA$3 million).

PSYGF